The University of Chicago Header Logo

Connection

Luciana Molinero to Uterine Cervical Neoplasms

This is a "connection" page, showing publications Luciana Molinero has written about Uterine Cervical Neoplasms.
Connection Strength

0.189
  1. A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04). Int J Gynecol Cancer. 2024 Aug 05; 34(8):1140-1148.
    View in: PubMed
    Score: 0.189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.